Eagleeye ji, Lauras Lab ke liye maximum shares per application kitne apply kar sakenge,? कृपया बताये ।upper ceilings kitni hai? Gmp bhi bta dena.
For FY 2016, Laurus Labs had basic earnings per share (EPS) of INR20.86 while diluted EPS stood at INR13.48 on a consolidated basis. The price band of INR426 – 428 per share values the company at a PE ratio of 31.6 – 31.75. These are rich valuations considering sub-30 figures for listed peers like Aurobindo Pharma and Divis Laboratories.
36.1. ShareView| Link| Bookmark|
December 2, 2016 10:02:52 AM
IPO Guru (2300+ Posts, 3600+ Likes)
Dear Experts , w.r.t P/E , This point is remarkable. Divis Lab is trading @ 29 p/e & Auropharma trading @ 22 p/e Co. specified in the ''basis of issue price''
No doubt Issue is good for listing gain But does it justify for long term ?
Laura''s March 2016 deluted E P S - 13.48 the PE is 31.75 it at higher side if you compare the peers Devi labs .and aurbindo pharma is available at lower PE to Laura''s lab also RONW is around 15%that is also at lower side think before applying.or buy the market leaders from the market,
Stand alone is with reference to the financials of only that company. If that company has 100% subsidiary companies in India or Abroad, all these financials have to be clubbed and represented as Consolidated. It is better to see the consolidated financials before buying.
28. gamble| Link| Bookmark|
December 1, 2016 8:11:04 AM
(1600+ Posts, 3900+ Likes)
Wait for june,sept 2016-17 data of laurus lab for finl call.